Riluzole for Degenerative Cervical Myelopathy: A Secondary Analysis of the CSM-PROTECT Trial.
Fehlings MG, Pedro KM, Alvi MA, Badhiwala JH, Ahn H, Farhadi HF, Shaffrey CI, Nassr A, Mummaneni P, Arnold PM, Jacobs WB, Riew KD, Kelly M, Brodke DS, Vaccaro AR, Hilibrand AS, Wilson J, Harrop JS, Yoon ST, Kim KD, Fourney DR, Santaguida C, Massicotte EM, Huang P.
Fehlings MG, et al. Among authors: jacobs wb.
JAMA Netw Open. 2024 Jun 3;7(6):e2415643. doi: 10.1001/jamanetworkopen.2024.15643.
JAMA Netw Open. 2024.
PMID: 38904964
Free PMC article.
Clinical Trial.